WHO recommends use of Regeneron’s Covid-19 antibody drug cocktail
The development is based on a British trial in 9,000 subjects, in which the antibody cocktail lowered mortality in hospitalised patients.
Regulation
Will Covid-19 vaccines be approved for young children?
Some vaccine makers are seeking regulatory approval for children younger than 12 years old.
FDA approves Pfizer Covid vaccine booster shot for older population
A third vaccine dose is intended for people at high risk and those prone to...
Waning Covid-19 vaccine efficacy: what does the data show?
While Covid-19 vaccines’ protection does appear to wane, most experts agree that universal booster rollouts...
Samsung Bioepis-Biogen’s biosimilar for Lucentis obtains FDA approval
With the approval, Biogen will oversee the commercialisation of SB11 under the brand name Byooviz...
FDA panel favours Pfizer-BioNTech’s Covid-19 booster shot for elderly
The committee also recommends granting EUA to the booster for use in some people at higher risk of severe Covid-19.
Korean MFDS approves Celltrion’s regdanvimab for Covid-19 treatment
In the Phase III trial, regdanvimab demonstrated a 72% reduction in the risk of Covid-19-linked hospitalisation or mortality.
Lilly’s Covid-19 antibody combo EUA expands for post-exposure prophylaxis
The authorisation comes after the US Government resumed the supply of bamlanivimab and etesevimab together.
Health Canada grants full approval to Moderna and Pfizer Covid-19 shots
Both vaccines received Canadian authorisation under an Interim Order in December last year.
Covid-19 vaccine boosters not widely needed, say top FDA and WHO scientists
The comments come as the US government gears up to roll out vaccine booster shots to the general public later this month.
UK MHRA approves Amgen’s sotorasib for non-small cell lung cancer treatment
With the approval, the drug will be offered under NHS to eligible lung cancer patients in England soon.
